Test Code LGBBS Globotriaosylsphingosine, Blood Spot
Test Down Notes
Effective September 21, 2023: This test is temporarily unavailable due to analytic issues. The downtime is expected to be >30 days. Order LGB3S as an alternative. See test notification here.
Ordering Guidance
Serum is the recommended specimen type for diagnosing and monitoring patients with Fabry Disease. For more information see LGB3S / Globotriaosylsphingosine, Serum.
Specimen Required
Supplies:
-Card-Blood Spot Collection (Filter Paper) (T493)
-Card Postmortem Screening (Filter Paper) (T525)
Container/Tube:
Preferred: Blood Spot Collection Card (Filter Paper)
Acceptable: Whatman Protein Saver 903 filter paper, PerkinElmer 226 filter paper, Munktell filter paper, Postmortem Screening Card or collected with EDTA, sodium heparin, lithium heparin, or ACD B-containing devices
Specimen Volume: 2 Blood spots
Collection Instructions:
1. An alternative blood collection option for a patient older than 1 year is a fingerstick. For detailed instructions, see How to Collect a Dried Blood Spot Sample.
2. Let blood dry completely on filter paper at ambient temperature in a horizontal position for a minimum of 3 hours.
3. At least 1 spot should be complete,(ie, unpunched).
4. Do not expose specimen to heat or direct sunlight.
5. Do not stack wet specimens.
6. Keep specimen dry.
Additional Information:
1. For collection instructions, see Blood Spot Collection Instructions.
2. For collection instructions in Spanish, see Blood Spot Collection Card-Spanish Instructions (T777).
3. For collection instructions in Chinese, see Blood Spot Collection Card-Chinese Instructions (T800).
Forms
Useful For
Screening of patients with Fabry disease using dried blood spots when a serum specimen is not available
This test should not be used for newborn screening followup.
Special Instructions
Reporting Name
Globotriaosylsphingosine, BSSpecimen Type
Whole bloodSpecimen Minimum Volume
1 Blood spot
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Whole blood | Refrigerated (preferred) | 10 days | FILTER PAPER |
| Frozen | 59 days | FILTER PAPER | |
| Ambient | 10 days | FILTER PAPER |
Reject Due To
| Blood spot specimen that shows serum rings or has multiple layers | Reject |
| Insufficient specimen | Reject |
Reference Values
Cutoff: ≤0.034 nmol/mL
Method Description
A 3-mm dried blood spot is extracted with internal standard. The extract is subjected to liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis. The MS/MS is operated in the multiple reaction monitoring positive mode to follow the precursor to product species transitions for each analyte and internal standard. The ratio of the extracted peak areas to internal standard is determined by LC-MS/MS is used to calculate the concentration of in the sample.(Unpublished Mayo method)
Day(s) Performed
Tuesday
Report Available
3 to 9 daysSpecimen Retention Time
Normal result: 2 months; Abnormal result: IndefinitelyPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
82542
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| LGBBS | Globotriaosylsphingosine, BS | 92754-1 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| BA4368 | Interpretation (LGBBS) | 59462-2 |
| BA4367 | Globotriaosylsphingosine | 92754-1 |
| BA4369 | Reviewed By | 18771-6 |